Viking Therapeutics Inc (VKTX)
74.31
+5.45
(+7.91%)
USD |
NASDAQ |
Apr 26, 16:00
74.69
+0.38
(+0.51%)
After-Hours: 20:00
Viking Therapeutics Total Assets (Quarterly): 967.52M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 967.52M |
| December 31, 2023 | 368.49M |
| September 30, 2023 | 382.66M |
| June 30, 2023 | 400.69M |
| March 31, 2023 | 150.90M |
| December 31, 2022 | 168.53M |
| September 30, 2022 | 166.68M |
| June 30, 2022 | 181.51M |
| March 31, 2022 | 195.03M |
| December 31, 2021 | 210.66M |
| September 30, 2021 | 224.47M |
| June 30, 2021 | 237.84M |
| March 31, 2021 | 250.14M |
| December 31, 2020 | 256.50M |
| September 30, 2020 | 263.62M |
| June 30, 2020 | 271.20M |
| March 31, 2020 | 277.10M |
| December 31, 2019 | 284.26M |
| September 30, 2019 | 290.12M |
| June 30, 2019 | 294.49M |
| Date | Value |
|---|---|
| March 31, 2019 | 300.08M |
| December 31, 2018 | 302.31M |
| September 30, 2018 | 306.80M |
| June 30, 2018 | 144.47M |
| March 31, 2018 | 78.97M |
| December 31, 2017 | 22.12M |
| September 30, 2017 | 11.84M |
| June 30, 2017 | 14.32M |
| March 31, 2017 | 15.15M |
| December 31, 2016 | 14.54M |
| September 30, 2016 | 16.32M |
| June 30, 2016 | 18.55M |
| March 31, 2016 | 12.76M |
| December 31, 2015 | 15.44M |
| September 30, 2015 | 19.01M |
| June 30, 2015 | 22.27M |
| March 31, 2015 | 2.769M |
| December 31, 2014 | 3.043M |
| June 30, 2014 | 2.014M |
| March 31, 2014 | 0.2767M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
150.90M
Minimum
Mar 2023
967.52M
Maximum
Mar 2024
292.12M
Average
260.06M
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 64.01B |
| Pfizer Inc | 226.50B |
| Madrigal Pharmaceuticals Inc | 640.55M |
| Akero Therapeutics Inc | 580.27M |
| Terns Pharmaceuticals Inc | 268.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.63M |
| Shareholders Equity (Quarterly) | 933.89M |